Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYCS | P99999 | 4/20 | 0.97 |
| ▸ | TOP1 | P11387 | 4/20 | 0.97 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709532 | 0.98 | TOP1 (1.00) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL29354037 | 0.98 | TOP1 (1.00) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL31463632 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| Hydrochloric Acid SCHEMBL17002623 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL31463629 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL19640853 | 0.97 | CYCS (1.00) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL17183606 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL1497141 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL3047596 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL31463636 | 0.97 | TOP1 (0.97) | CYCSTOP1ENPP2ABCG2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395275-A1 | COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF HYDROCARBON ISOMERS | UNITED STATES DEPARTMENT OF ENERGY | 2021-12-23 | — | — | US | disclosed |
| WO-2019157013-A1 | COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF HYDROCARBON ISOMERS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2019-08-15 | — | — | WO | disclosed |
| US-20110064694-A1 | ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES | YALE UNIVERSITY (US) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395275-A1 | COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF HYDROCARBON ISOMERS | TIMCC, TRPC4, TRPC6 | CYCS 127/4885TOP1 1542/4885ENPP2 542/4885 |
| US-20110064694-A1 | ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES | HAVCR2, HCCS, HMBS | CYCS 33/4885TOP1 2148/4885ENPP2 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.